Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics

被引:62
作者
Michael, Mandel D. [1 ]
Balint, Anita [2 ]
Lovasz, Barbara D. [1 ]
Gulacsi, Laszlo [3 ]
Strbak, Balint [3 ]
Golovics, Petra A. [1 ]
Farkas, Klaudia [2 ]
Kuerti, Zsuzsanna [1 ]
Szilagyi, Blanka K. [1 ]
Mohas, Anna [1 ]
Molnar, Tamas [2 ]
Lakatos, Peter L. [1 ]
机构
[1] Semmelweis Univ, Dept Med 1, H-1083 Budapest, Hungary
[2] Univ Szeged, Dept Med 1, H-6720 Szeged, Hungary
[3] Corvinus Univ Budapest, Dept Hlth Econ, H-1093 Budapest, Hungary
关键词
UC; CD; Work disability; Productivity loss; Anti-TNF; Hungary; QUALITY-OF-LIFE; CROHNS-DISEASE; RHEUMATOID-ARTHRITIS; ULCERATIVE-COLITIS; INDIRECT COSTS; BURDEN; EUROPE;
D O I
10.1007/s10198-014-0603-7
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background and aims To assess work disability (WD) rates in an inflammatory bowel disease (IBD) cohort involving patients with Crohn's disease (CD) or ulcerative colitis (UC) cohort and to identify possible clinical or demographic factors associated with WD. To our knowledge, this is the first study from Eastern Europe that has estimated indirect costs in IBD. Methods Data from 443 (M/F: 202/241, CD/UC: 260/183, mean age: 35.5 (CD) and 40.5 (UC) years, biological drug exposure 31.2/11.5 %) consecutive patients were included. WD data were collected by questionnaire and the work productivity and activity impairment instrument. Disability pension (DP) rates in the general population were retrieved from public databases. Results The overall DP rate in this IBD population was 32.3 %, with partial disability in 24.2 %. Of all DP events, 88.8 % were directly related to IBD. Overall, full DP was more prevalent in IBD (RR: 1.51, p < 0.001) and CD (RR: 1.74, p < 0.001) but not in UC compared to the general population and also in CD compared to UC (OR 1.57, p = 0.03). RR for full DP was increased only in young CD patients (RR<35 year olds: 9.4; RR36-40 year olds: 9.4 and 5.6, p < 0.01 for both). In CD, age group, previous surgery, disease duration, frequent relapses, and the presence of arthritis/arthralgia were associated with an increased risk for DP. Among employed patients, absenteeism and presenteeism was reported in of 25.9 and 60.3 % patients, respectively, leading to a 28 % loss of work productivity and a 32 % activity loss, and was associated with disease activity and age group. Average cost of productivity loss due to disability and sick leave with a human capital approach was 1,450 and 430 (sic)/patient/year in IBD, respectively (total productivity loss 1,880 (sic)/patient/year), the costs of presenteeism were 2,605 (SD = 2,770) and 2,410 (SD = 2,970) (sic)/patient/year in CD and UC, respectively. Conclusion Risk of DP was highly increased in young CD patients (sixfold to ninefold). Previous surgery and presence of arthritis/arthralgia was identified as risk factors for DP. Work productivity is significantly impaired in IBD and is associated with high productivity loss.
引用
收藏
页码:S121 / S128
页数:8
相关论文
共 31 条
  • [1] Permanent work disability in Crohn's disease
    Ananthakrishnan, Ashwin N.
    Weber, Lydia R.
    Knox, Josh F.
    Skaros, Susan
    Emmons, Jeanne
    Lundeen, Sarah
    Issa, Mazen
    Otterson, Mary F.
    Binion, David G.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (01) : 154 - 161
  • [2] Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease
    Bernklev, T
    Jahnsen, J
    Henriksen, M
    Lygren, I
    Aadland, E
    Sauar, J
    Schulz, T
    Stray, N
    Vatn, M
    Moum, B
    [J]. INFLAMMATORY BOWEL DISEASES, 2006, 12 (05) : 402 - 412
  • [3] Hospitalisations and surgery in Crohn's disease
    Bernstein, Charles N.
    Loftus, Edward V., Jr.
    Ng, Siew C.
    Lakatos, Peter L.
    Moum, Bjorn
    [J]. GUT, 2012, 61 (04) : 622 - 629
  • [4] BEST WR, 1976, GASTROENTEROLOGY, V70, P439
  • [5] The impact of inflammatory bowel disease on labor force participation:: Results of a population sampled case-control study
    Boonen, A
    Dagnelie, PC
    Feleus, A
    Hesselink, MA
    Muris, JW
    Stockbrügger, RW
    Russel, MG
    [J]. INFLAMMATORY BOWEL DISEASES, 2002, 8 (06) : 382 - 389
  • [6] Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease
    Bouguen, Guillaume
    Levesque, Barrett G.
    Feagan, Brian G.
    Kavanaugh, Arthur
    Peyrin-Biroulet, Laurent
    Colombel, Jean-Frederic
    Hanauer, Stephen B.
    Sandborn, William J.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (06) : 1042 - +
  • [7] BRODSZKY V, 2009, HUNG EXP RHEUMATOL I, V30, P199
  • [8] The burden of inflammatory bowel disease in Europe
    Burisch, Johan
    Jess, Tine
    Martinato, Matteo
    Lakatos, Peter L.
    [J]. JOURNAL OF CROHNS & COLITIS, 2013, 7 (04) : 322 - 337
  • [9] Quantifying the economic burden of productivity loss in rheumatoid arthritis
    Filipovic, Ivana
    Walker, David
    Forster, Fiona
    Curry, Alistair S.
    [J]. RHEUMATOLOGY, 2011, 50 (06) : 1083 - 1090
  • [10] Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study
    Gibson, Peter R.
    Vaizey, Carolynne
    Black, Christopher M.
    Nicholls, Rebecca
    Weston, Adele R.
    Bampton, Peter
    Sparrow, Miles
    Lawrance, Ian C.
    Selby, Warwick S.
    Andrews, Jane M.
    Walsh, Alissa J.
    Hetzel, David J.
    Macrae, Finlay A.
    Moore, Gregory T.
    Weltman, Martin D.
    Leong, Rupert W.
    Fan, Tao
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 (07) : 598 - 606